Abstract:Ferroptosis is a recently recognized form of regulated cell death. It is characterized morphologically by the presence of smaller than normal mitochondria with condensed mitochondrial membrane densities, reduction or vanishing of mitochondria crista, and outer mitochondrial membrane rupture. It can be induced by experimental compounds (e.g., erastin, Ras-selective lethal small molecule 3, and buthionine sulfoximine) or clinical drugs (e.g., sulfasalazine, sorafenib, and artesunate) in cancer cells and certain normal cells (e.g., kidney tubule cells, neurons, fibroblasts, and T cells). Activation of mitochondrial voltage-dependent anion channels and mitogen-activated protein kinases, upregulation of endoplasmic reticulum stress, and inhibition of cystine/glutamate antiporter is involved in the induction of ferroptosis. This process is characterized by the accumulation of lipid peroxidation products and lethal reactive oxygen species (ROS) derived from iron metabolism and can be pharmacologically inhibited by iron chelators (e.g., deferoxamine and desferrioxamine mesylate) and lipid peroxidation inhibitors (e.g., ferrostatin, liproxstatin, and zileuton). Glutathione peroxidase 4, heat shock protein beta-1, and nuclear factor erythroid 2-related factor 2 function as negative regulators of ferroptosis by limiting ROS production and reducing cellular iron uptake, respectively. In contrast, NADPH oxidase and p53 (especially acetylation-defective mutant p53) act as positive regulators of ferroptosis by promotion of ROS production and inhibition of expression of SLC7A11 (a specific light-chain subunit of the cystine/glutamate antiporter), respectively. Misregulated ferroptosis has been implicated in multiple physiological and pathological processes, including cancer cell death, neurotoxicity, neurodegenerative diseases, acute renal failure, drug-induced hepatotoxicity, hepatic and heart ischemia/reperfusion injury, and T-cell immunity. In this review, we summarize the regulation mechanisms and signaling pathways of ferroptosis and discuss the role of ferroptosis in disease.

Microglial ferroptotic stress causes non-cell autonomous neuronal death

Insight into the Role of Ferroptosis in Non-neoplastic Neurological Diseases

Ferroptosis and Its Multifaceted Roles in Cerebral Stroke

Microglia ferroptosis is prevalent in neurodegenerative disease and regulated by SEC24B

Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration

Ferroptosis, a Recent Defined Form of Critical Cell Death in Neurological Disorders

Iron metabolism mediates microglia susceptibility in ferroptosis

Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis

Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease

Ferroptosis: molecular mechanisms and health implications

Mechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases

Role of ferroptosis in neurological diseases

Ferroptosis: process and function

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

The calcium-iron connection in ferroptosis-mediated neuronal death

Ferroptosis: underlying mechanisms and involvement in neurodegenerative diseases

Ferroptosis, a Regulated Neuronal Cell Death Type After Intracerebral Hemorrhage

The role of ferroptosis in central nervous system damage diseases

Cerebral ischemia induced iron deposit, ferritin accumulation, nuclear receptor coactivator 4-depletion and ferroptosis.

Ferroptosis Signaling Pathways: Alzheimer's Disease

Ferroptosis: mechanisms and links with diseases